NEWS
Reduce barriers
Another goal of the educational platform
is to reduce barriers to the adoption of
diabetes digital tools. DTN UK/ABCD
provides guidance on educational content
and ensures that the programme aligns
with current and future National Health
Service England (NHSE) policy/pathways.
Healthcare professionals earn Continuous
Personal Development accreditation for
completing the programme.
Russ Johannesson, Chief Executive
Officer of Glooko commented, "Academy
is an important investment that sets a new
standard for professional development
in the diabetes medical technology
industry. In collaboration with the NHSE
and DTN UK/ABCD, we've developed
a new, extensive curriculum that will
not only equip HCPs to access training
that is relevant to their technology skills
development, but it will also build a wider
range of their capabilities as we move
increasingly towards a remote patient
monitoring environment. The curriculum
covers more than 95% of the current
diabetes device makers and their tech."
Prof. Pratik Choudhary, Professor in
Diabetes and Chair of DTN UK remarked
on the launch saying, "As diabetes
technology becomes increasingly
widespread in routine clinical practice,
we need to train all levels of our diabetes
and wider health workforce in what these
technologies are and how to use the large
amounts of data they generate. Use of
these technologies has transformed how
we deliver care, especially during these
challenging times. We firmly believe that
the collective efforts that we're cultivating
with world-class digital health companies
like Glooko will create more value and
positively impact outcomes that matter to
people with diabetes."
Additionally, Prof. Partha Kar, National
Specialty Advisor of Diabetes at NHS
England, stated: "As Nick Fury once said
in The Avengers 'There was an idea.' It's
been a pleasure to bring together multiple
partners across industry, specialists in
diabetes care, facilitated by Glooko for
this project. As diabetes technologies
continually advance and improve, it's
critical that healthcare providers have
access to the most exceptional training on
the plethora of devices that people with
diabetes now use on a daily basis. This
platform will hopefully go a long way in
ensuring education is available uniformly
across the NHS, thereby improving
access and outcomes for those living with
diabetes."
Sources:
1. Diabetes Facts and Stats: 2015 -
Diabetes UK, 2015
2. Diabetes Self-management Education
and Support in Adults With Type 2
As diabetes technologies continually advance
and improve, it's critical that healthcare providers
have access to the most exceptional training on
the plethora of devices that people with diabetes
use on a daily basis. - Prof Partha Kar"
What is Glooko?
Glooko (known as Diasend in the UK) is
developing online education experiences
that complement its portfolio of diabetes
digital health solutions. The Academy
programme is part of Glooko's global
mission to improve health outcomes by
connecting people with diabetes and
their healthcare professionals, enabling
telehealth, clinical research and improved
collaboration. The software platforms
Glooko and Diasend empower diabetes
management by collecting from bloodglucose meters, CGMs, insulin pumps,
pens, and activity trackers, bringing
insights together in one place. Data is
easily uploaded - remotely via app or inclinic, securely
shared, and visualized in
actionable charts and graphs. This creates
a solid foundation enabling collaboration
and confident treatment decisions.
www.glooko.com
As diabetes technology becomes increasingly
widespread in routine clinical practice, we need
to train all levels of our diabetes and wider health
workforce in what these technologies are and how
to use the large amounts of data they generate.
- Prof Pratik Choudhary"